• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机金属抗癌药物干扰细胞能量过程:诱导癌细胞死亡的微妙方法。

Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.

机构信息

Institute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology, 1015 Lausanne, Switzerland.

出版信息

Dalton Trans. 2013 Feb 21;42(7):2347-50. doi: 10.1039/c2dt31936e. Epub 2012 Dec 5.

DOI:10.1039/c2dt31936e
PMID:23223548
Abstract

Two hybrid compounds comprising an antimetastatic ruthenium-arene fragment tethered to an indazole-3-carboxylic acid derivative that inhibits aerobic glycolysis in cancer cells have been prepared and evaluated in a variety of cancer cell lines, including highly relevant human glioblastoma cells, with an apparent synergistic action between the two components observed.

摘要

已经制备了两种包含反转移金属钌-芳烃片段与抑制癌细胞有氧糖酵解的吲唑-3-羧酸衍生物连接的混合化合物,并在多种癌细胞系(包括高度相关的人胶质母细胞瘤细胞)中进行了评估,观察到两种成分之间存在明显的协同作用。

相似文献

1
Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.有机金属抗癌药物干扰细胞能量过程:诱导癌细胞死亡的微妙方法。
Dalton Trans. 2013 Feb 21;42(7):2347-50. doi: 10.1039/c2dt31936e. Epub 2012 Dec 5.
2
Arene ruthenium complexes as anticancer agents.钌芳配合物作为抗癌剂。
Dalton Trans. 2010 Feb 21;39(7):1673-88. doi: 10.1039/b916860p. Epub 2009 Oct 23.
3
A novel ruthenium(II) arene based intercalator with potent anticancer activity.一种具有强大抗癌活性的新型钌(II)芳烃基嵌入剂。
Dalton Trans. 2009 Jul 14(26):5071-3. doi: 10.1039/b907296a. Epub 2009 May 12.
4
Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.合成具有(N,N)、(N,O)和(O,O)配位双齿配体的铱和钌配合物作为潜在的抗癌剂。
Dalton Trans. 2012 Dec 7;41(45):13800-2. doi: 10.1039/c2dt32104a. Epub 2012 Sep 27.
5
Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis.与金属有机钌药效团络合增强了 4-苯胺基喹唑啉诱导细胞凋亡的能力。
Chem Commun (Camb). 2013 Nov 11;49(87):10224-6. doi: 10.1039/c3cc43000f.
6
Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.具有 Os(II) 配合物的环金属化化合物对癌细胞的细胞毒性。
Inorg Chem. 2013 Mar 4;52(5):2705-15. doi: 10.1021/ic302779q. Epub 2013 Feb 21.
7
New titanocene derivatives with high antiproliferative activity against breast cancer cells.新型高增殖活性的钛茂衍生物对抗乳腺癌细胞。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):136-40. doi: 10.1016/j.bmcl.2013.11.058. Epub 2013 Dec 3.
8
Enhancement of cytotoxicity by combining pyrenyl-dendrimers and arene ruthenium metallacages.通过将芘基树状大分子与芳烃钌金属笼结合来增强细胞毒性。
Inorg Chem. 2012 Jul 2;51(13):7119-24. doi: 10.1021/ic202739d. Epub 2012 Jun 20.
9
Design of Ru-arene Complexes for Antitumor Drugs.用于抗肿瘤药物的钌-芳烃配合物的设计
Mini Rev Med Chem. 2018;18(2):184-193. doi: 10.2174/1389557517666170510113453.
10
Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.抗水解的有机金属钌-芳烃抗癌药物的研发。
Inorg Chem. 2006 Oct 30;45(22):9006-13. doi: 10.1021/ic061008y.

引用本文的文献

1
New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents.具有氯尼达明结构单元的新型有机金属钌(II)化合物作为抗肿瘤剂
Pharmaceutics. 2023 Apr 29;15(5):1366. doi: 10.3390/pharmaceutics15051366.
2
Dimethyl Sulfoxide: A Bio-Friendly or Bio-Hazard Chemical? The Effect of DMSO in Human Fibroblast-like Synoviocytes.二甲基亚砜:生物友好还是生物危害化学物质?二甲基亚砜对人成纤维样滑膜细胞的影响。
Molecules. 2022 Jul 13;27(14):4472. doi: 10.3390/molecules27144472.
3
Ru(III) Complexes with Lonidamine-Modified Ligands.钌(III)配合物与洛尼达明修饰配体。
Int J Mol Sci. 2021 Dec 15;22(24):13468. doi: 10.3390/ijms222413468.
4
Understanding the interactions of diruthenium anticancer agents with amino acids.理解双钌抗癌药物与氨基酸的相互作用。
J Biol Inorg Chem. 2018 Oct;23(7):1159-1164. doi: 10.1007/s00775-018-1597-x. Epub 2018 Jul 25.
5
X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism.与人类血清白蛋白结合的吲唑鎓反式-[四氯双(1H-吲唑)钌(III)](KP1019)的X射线结构分析揭示了两个钌结合位点,并为药物结合机制提供了见解。
J Med Chem. 2016 Jun 23;59(12):5894-903. doi: 10.1021/acs.jmedchem.6b00600. Epub 2016 Jun 7.
6
Organometallic Half-Sandwich Dichloridoruthenium(II) Complexes with 7-Azaindoles: Synthesis, Characterization and Elucidation of Their Anticancer Inactivity against A2780 Cell Line.含7-氮杂吲哚的有机金属半夹心二氯钌(II)配合物:其对A2780细胞系抗癌无活性的合成、表征及阐释
PLoS One. 2015 Nov 25;10(11):e0143871. doi: 10.1371/journal.pone.0143871. eCollection 2015.
7
Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes.专题编辑:钌配合物:钌配合物不断扩展的化学性质
Molecules. 2015 Sep 18;20(9):17244-74. doi: 10.3390/molecules200917244.